Pacific Biosciences of California PACB Convertible Preferred Stock Authorized Shares
Convertible Preferred Stock Authorized Shares at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's convertible preferred stock authorized shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's convertible preferred stock authorized shares?
- Pacific Biosciences of California (PACB) reported convertible preferred stock authorized shares of 50M in Q1 2026.
- How has Pacific Biosciences of California's convertible preferred stock authorized shares changed year-over-year?
- Pacific Biosciences of California's convertible preferred stock authorized shares decreased by 0.0% year-over-year, from 50M to 50M.
- What is the long-term trend for Pacific Biosciences of California's convertible preferred stock authorized shares?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's convertible preferred stock authorized shares has grown at a 0.0% compound annual growth rate (CAGR), from 50M to 50M.
- What does convertible preferred stock authorized shares mean?
- Maximum number of convertible preferred shares the company is authorized to issue under its corporate charter.